Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
macromolecular complexes and use these properties to develop new tools and novel therapeutics. As a successful candidate, you will: · Conducts routine and specialized laboratory experiments in Molecular
-
, shaping the future of medicine through cutting-edge research. A Research Associate II position is available in the laboratory of Dr. Ke Ma. The Ma lab applies state-of-the-art circadian biology, molecular
-
&sort=date As a successful candidate, you will: · Work on stem cells, genome editing, HTS, pancreatic islet biology and diabetes. · Skills that are required for the lab are molecular
-
, Alzheimer’s, and sickle cell disease, while also applying our techniques to molecular dynamics simulations of proteins and complexes. As a successful candidate, you will: Develop novel probabilistic network
-
using transgenic and transplantation mouse models of lymphoproliferative diseases, primary cells from patients, humanized mice, gene editing, classical molecular, cell biology, and biochemistry, and
-
xenotransplantation models, and utilizing bioluminescence imaging. Employ molecular biology and biochemistry techniques such as retroviral/lentiviral transduction, molecular cloning, high-throughput RNA/DNA sequencing
-
position is available in the laboratory of Dr. Ke Ma. The Ma lab applies state-of-the-art circadian biology, molecular and cellular biology approaches to diabetes and obesity research, with an ultimate goal
-
II position is available in the laboratory of Dr. Ke Ma. The Ma lab applies state-of-the-art circadian biology, molecular and cellular biology approaches to diabetes and obesity research, with
-
. · Experience in cellular immunology and/or tumor immunology as well as molecular biology. · Proficiency with murine tumor models and multicolor flow cytometry. · Experience managing others by
-
resume’, your questions and a friend! *All are welcome. More about Dr Goel here: Ajay Goel, Ph.D., AGAF, Chair, Department of Molecular Diagnostics and Experimental Therapeutics | Beckman Research